Dr. Michael D. Rokaw, MD

Dr. Rokaw practices at Fresenius Medical Care Pierremont in Shreveport, Louisiana.

Dr. Rokaw's NPI, 1154317469, was assigned on September 22, 2005. Dr. Rokaw graduated from University at Buffalo School of Medicine in 1988. Dr. Rokaw holds Louisiana license 13152R.

Dr. Rokaw's primary practice is Fresenius Medical Care Pierremont, at 1800 Buckner St, Shreveport, LA 71101 in Caddo Parish. The practice phone is (318) 524-9906.

Dr. Rokaw's primary practice is Fresenius Medical Care Pierremont in Shreveport, Louisiana. Dr. Rokaw is also affiliated with Willis Knighton North. The medical group on file is Northwest Louisiana Nephrology. Dmand AI also links Dr. Rokaw to 4 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rokaw practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Rokaw's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Rokaw is board certified in internal medicine by the American Board of Internal Medicine. Dr. Rokaw is licensed in Louisiana.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia and kidney cysts among the conditions Dr. Rokaw treats.

CMS data shows 2,164 Medicare services from Dr. Rokaw across 20 procedure codes in 2024, for 570 Medicare patients. Medicare paid $186,978 for them.

CMS counts 570 Medicare patients who saw Dr. Rokaw in 2024. The largest group is 75 to 84, with 199 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 4.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rokaw's median patient age at 70, with 48% women.

In 2024, Dr. Rokaw wrote 1,092 Medicare Part D claims for 169 patients. 87% of them were for generic drugs. CMS names the drug for 779 of them, across 24 drugs with 11 or more claims each, at $97,687 in total drug cost. In 2023, CMS named 1,057 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Rokaw for performance year 2024, reported as part of a group. Dr. Rokaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Rokaw.

CMS Open Payments shows 250 general payments to Dr. Rokaw from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Fresenius USA Marketing, Inc. paid the most, $601.

Dr. Rokaw graduated from University at Buffalo School of Medicine in 1988.

Dr. Rokaw is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.